The IMID Forum

Kevin Winthrop, Professor of infectious diseases and public health at the Oregon Health & Science University in Portland, Oregon. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Kevin Winthrop discusses infections in baricitinib clinical trials for patients with active RA.

Dr Pedro López-Romero, a senior research scientist from Lilly, and Dr Eugen Feist from the Charité. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, they discuss anti-CarbV and anti-MCV titres as predictors for improvements in SDAI score and radiographic progression in patients with RA.

Prof Iain McInnes discusses the risk of infection and cardiovascular events associated with JAK inhibitors. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed in this podcast is available in a more detailed slide format in the publications section at cytokinesignalling.com.

Pharmacoepidemiology research group leader at the German Rheumatism Research Centre, Berlin, Germany, and Scientific Director of the Institute of Musculoskeletal Health, Madrid, Spain. In this podcast, Professor Strangfeld and Professor Carmona discuss the use of registries in the field of rheumatology, giving insight into their experiences with developing data collection strategies over the years and translating it to clinical research. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.

Vice Chair of the Cleveland Clinic's Department of Rheumatic and Immunologic Diseases in Cleveland, Ohio. In this podcast, Prof Leonard Calabrese discusses his interest in rheumatology, his work considering the interface between rheumatic diseases and infection, and the significance of herpes zoster in inflammatory disease. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.

Vibeke Strand, Adjunct Clinical Professor in the Division of Immunology and Rheumatology in the Stanford University School of Medicine. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Vibeke Strand discusses the safety and efficacy of upadacitinib monotherapy in RA.

Chair of Department of Rheumatology in the Hospital Italiano, Buenos Aires, Argentina. In this podcast, Dr Soriano discusses his interest in Rheumatology, and his current research collaboration across Argentina.

Prof Iain McInnes discusses the safety and efficacy of baricitinib and upadacitinib as monotherapy treatments in RA. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed in this podcast is available in a more detailed slide format in the publications section at cytokinesignalling.com.

Professor Roy Fleischmann from the University of Texas Southwestern Medical Center, Dallas. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Roy Fleischmann discusses the safety and efficacy of long-term baricitinib monotherapy in RA.

Prof Kosuke Ebina from the University of Osaka, Japan. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Kosuke Ebina discusses drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with RA using real-world data from the ANSWER registry.